Explores the mental, physical, cellular and biochemical aspects of environmental illnesses such as obesity, diabetes, chronic fatigue syndrome, PTSD, fibromyalgia, chemical sensitivities, neurological disorders and numerous others. We advocate for better access to medical care, healthier lifestyles, resource conservation and the use of assistance animals for the disabled to promote a better quality of life.
Tuesday, December 29, 2009
GSK-3b is required for hyperdopamine and d2 receptor-mediated inhibition of synaptic nmda receptor function in the rat prefrontal cortex.
Summary: This study suggests that GSK-3beta is required for the hyperdopamine/D(2) receptor-mediated inhibition of NMDA receptors in the prefrontal neurons and these actions may underlie D(2) receptor-mediated psychostimulant effects and hyperdopamine-dependent behaviors in the brain.Li, Y.-C. C., Xi, D., Roman, J., Huang, Y.-Q. Q., and Gao, W.-J. J. (2009). Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and d2 receptor-mediated inhibition of synaptic nmda receptor function in the rat prefrontal cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience, 29(49):15551-15563. http://www.citeulike.org/user/HEIRS/article/6347607#
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment